Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Results of phase II evaluation of evacetrapib presented

Dec. 5, 2011

Generex provides update on clinical and regulatory status of buccal insulin spray

Dec. 2, 2011

Evotec patents novel orexin OX2 receptor antagonists

Dec. 2, 2011

Omthera Pharmaceuticals completes enrollment in EVOLVE study

Dec. 1, 2011

Advinus Therapeutics completes proof-of-concept study of GKM-001

Dec. 1, 2011

Novel orexin receptor antagonists emerge from R&D at Evotec

Dec. 1, 2011

GlaxoSmithKline presents new AMPK activators

Dec. 1, 2011

BioMarin begins study of GALNS in young patients with MPS IVA

Nov. 30, 2011

University of Edinburgh discloses new 11-beta-HSD1 inhibitors

Nov. 30, 2011

FDA accepts Amarin's NDA for AMR-101

Nov. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...